
Professor
INA SALWANY
MD YASIN
Professor
INA SALWANY
MD YASIN
Researcher
Universiti Putra Malaysia
Biography
Prof. Dr. Ina Salwany is a distinguished researcher in fish vaccinology and aquatic animal health. She earned her PhD in Molecular Biology from Universiti Malaysia Terengganu in 2009, focusing on Pasteurella multocida gene expression. She later conducted postdoctoral research in Belgium on bacterial ITS gene amplification. Currently, she is a professor at Universiti Putra Malaysia (UPM) and Deputy Director of the Institute of Bioscience, UPM.
With over 15 years of experience, Prof. Ina has published 120+ journal papers and led numerous research projects, securing over MYR 19 million in research funding. Her work primarily focuses on fish disease epidemiology and the development of feed-based vaccines for aquaculture, including the patented ViVaC UPM vaccine against vibriosis. She has supervised over 50 postgraduate students and collaborated with international institutions, including Auburn University, Hokkaido University, and Universitas Airlangga. Prof. Ina has received multiple awards, including Outstanding Woman Researcher in Aquaculture 2024 and innovation medals for her vaccine developments. She also serves as an academic advisor and consultant for government and industry stakeholders, contributing significantly to fish health research and vaccine commercialization. Research interests
Prof. Dr. Ina Salwany's research focuses on advancing sustainable aquaculture through disease prevention, fish health management, and innovative vaccine development. Her work integrates molecular biology, microbiology, and immunology to address key challenges in aquatic animal health. Projects you're working on
Upscaling Production of a Feed-Based Vaccine against Vibriosis for Marine Fishes: A Comprehensive Evaluations of Economic Implications for Low Middle-Income Countries (LMICs) Discipline
Bacteriology Epidemiology Molecular biology Host species
Fish Pathogen
Bacteria Bacteria›Aeromonas Stage of vaccine development
Adjuvants Antigen discovery and immunogen design Commercialisation Field trials Pre-clinical trials Vaccine delivery